64 related articles for article (PubMed ID: 32871962)
1. Impact of mirna-21 on survival prognosis in patients with pancreatic cancer: A protocol for systematic review and meta-analysis.
Zhang W; Chen J; He G; Xu W; He G
Medicine (Baltimore); 2020 Aug; 99(35):e22045. PubMed ID: 32871962
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA as a biomarker for the prognosis of ischemic stroke: A protocol for meta-analysis and bioinformatics analysis.
Fu J; Yu Q; Xiao J; Li S
Medicine (Baltimore); 2021 Apr; 100(17):e25596. PubMed ID: 33907110
[TBL] [Abstract][Full Text] [Related]
3. Effect of FAT1 gene expression on the prognosis of medulloblastoma in children: A protocol for systematic review and meta-analysis.
Yu J; Gao H; Su Z; Yue F; Tian X
Medicine (Baltimore); 2020 Nov; 99(46):e23020. PubMed ID: 33181666
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis.
Li H; Yan M; Wu X; Wang Y; Huang L
Medicine (Baltimore); 2021 May; 100(18):e25545. PubMed ID: 33950928
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of long noncoding RNA urothelial carcinoma-associated 1 in esophageal carcinoma: A protocol for meta-analysis, TCGA data and bioinformatics analysis.
Zhang H; Tian J; Tang J; Wang T
Medicine (Baltimore); 2021 Apr; 100(16):e25452. PubMed ID: 33879677
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis.
Xiao D; Xie J; Wu S
Medicine (Baltimore); 2021 Jun; 100(22):e25830. PubMed ID: 34087825
[TBL] [Abstract][Full Text] [Related]
7. Relationship between long non-coding RNA and prognosis of patients with coronary heart disease after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Wang F; Cai X; Jiao P; Liu Y; Yuan B; Zhang P; Liu H; Ma L
Medicine (Baltimore); 2020 Dec; 99(51):e23525. PubMed ID: 33371075
[TBL] [Abstract][Full Text] [Related]
8. Relationship between ABO blood groups and gestational hypertensive disorders: A protocol for systematic review and meta-analysis.
Dilixiati N; Sui S; Ge X; Tuerxun D; Huang Y
Medicine (Baltimore); 2021 May; 100(18):e25573. PubMed ID: 33950933
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the practicability of ultrasound and spiral computed tomography in the diagnosis of colon cancer: A protocol for systematic review and meta-analysis.
Zhao F; Yang Q; Meng C; Jiang T
Medicine (Baltimore); 2020 Dec; 99(50):e23381. PubMed ID: 33327262
[TBL] [Abstract][Full Text] [Related]
10. The relationship between the expression of soluble programmed cell death-1 and cancer pain: A protocol for systematic review and meta analysis.
Zhu G; Jiang Y; Wang H; Shao S
Medicine (Baltimore); 2021 Apr; 100(17):e25555. PubMed ID: 33907102
[TBL] [Abstract][Full Text] [Related]
11. Effects of programmed death ligand 1 on the prognosis of neuroblastoma: A protocol for systematic review and meta analysis.
Wu Z; Wei F; Zou Y
Medicine (Baltimore); 2021 Mar; 100(9):e24920. PubMed ID: 33655954
[TBL] [Abstract][Full Text] [Related]
12. Liver stiffness measured by magnetic resonance elastography in early recurrence of hepatocellular carcinoma after treatment: A protocol for systematic review and meta analysis.
Zhao H; Zhang L; Chen H
Medicine (Baltimore); 2021 Jun; 100(23):e26183. PubMed ID: 34115001
[TBL] [Abstract][Full Text] [Related]
13. The effects of LncRNA PVT1 on clinical characteristics and survival in breast cancer patients: A protocol for systematic review and meta analysis.
Xie L; Feng G; Zhu P; Xie J
Medicine (Baltimore); 2021 Feb; 100(8):e24774. PubMed ID: 33663093
[TBL] [Abstract][Full Text] [Related]
14. Potential value of tripartite motif-containing 59 as a biomarker for predicting the prognosis of patients with lung cancer: A protocol for systematic review and meta-analysis.
Guo J; Min K; Deng L
Medicine (Baltimore); 2021 Aug; 100(32):e26868. PubMed ID: 34397900
[TBL] [Abstract][Full Text] [Related]
15. The value of microRNA-21 as a biomarker for the prognosis of lung cancer: A protocol for systematic review and meta-analysis.
Zhang W; Wei L; Luo R; Liu H; Chen J
Medicine (Baltimore); 2020 Aug; 99(33):e21483. PubMed ID: 32871993
[TBL] [Abstract][Full Text] [Related]
16. Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis.
Tavano F; Fontana A; Mazza T; Gioffreda D; Biagini T; Palumbo O; Carella M; Andriulli A
Front Oncol; 2020; 10():1567. PubMed ID: 33072549
[TBL] [Abstract][Full Text] [Related]
17. The Role of microRNA in Pancreatic Cancer.
Smolarz B; Durczyński A; Romanowicz H; Hogendorf P
Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680441
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.
Stempor PA; Avni D; Leibowitz R; Sidi Y; Stępień M; Dzieciątkowski T; Dobosz P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806327
[TBL] [Abstract][Full Text] [Related]
19. Interplay between cyclooxygenase‑2 and microRNAs in cancer (Review).
Gong Z; Huang W; Wang B; Liang N; Long S; Li W; Zhou Q
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760116
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of microRNA-21 in epithelial ovarian carcinoma: A protocol for systematic review and meta analysis.
Ji K; Wang X; Zhang A; Wen H
Medicine (Baltimore); 2020 Dec; 99(52):e23849. PubMed ID: 33350775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
